Aulis Capital

Aulis Capital is a venture capital firm founded in 2025 and based in Palo Alto, California, focusing on the healthcare industry by partnering with early and growth stage companies and leveraging scientific, analytical and investment expertise to accelerate innovations that improve patient care and advance medical technology. The firm is led by foun... ding Managing Partner Nisa Leung, who previously served as Managing Partner at Qiming Venture Partners where she founded and led the firm's healthcare practice since 2006, establishing Qiming as a pioneering investor in healthcare and biotech sectors. Leung has been consistently recognized as one of the most influential investors in the industry, featured on the Forbes Midas List for six consecutive years from 2019 to 2024 and ranked among the Top 2 Best Women VCs by Forbes China for three successive years since 2021. In 2024, she was honored as one of Fortune Asia's Most Powerful Women and named among Fortune China's Most Powerful Women in Business from 2022 to 2024. Aulis Capital operates as a global investment firm specializing in healthcare and biotech investments, with a focus on supporting companies developing innovative medical technologies and therapeutic solutions. The firm has participated in significant healthcare investments, including joining as a new investor in EpiBiologics alongside other leading healthcare investors. Leung holds an MBA from Stanford Graduate School of Business and a BS from Cornell University. Prior to founding Aulis Capital, Leung co-founded Biomedic Holdings with operations and investments in medical devices, pharmaceuticals and healthcare services in China, and served as Venture Partner at PacRim Ventures in Menlo Park and previously with Softbank/Mobius Venture Capital.Read More